Paxlovid Is Now Less Effective Against Covid, Study Shows
Story by Nacha Cattan Sept 21, 2023 Bloomberg A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday.© Bloomberg (Bloomberg) — In a real-world study of people with Covid-19, Pfizer Inc.’s antiviral Paxlovid was less effective at […]